Clinical Study
P-Cresyl Sulfate Is a Valuable Predictor of Clinical Outcomes in Pre-ESRD Patients
Table 2
Clinical biochemistry of CKD patients divided by medium PCS concentration (6 mg/L).
| | Variables | P-cresyl sulfate
≧6.0 mg/L | P-cresyl sulfate
<6.0 mg/L | value | | () | () |
| | CKD stage (%) | | | | | 3 | 10.0% | 57.3% | <0.001 | | 4 | 24.5 % | 37.5% | <0.001 | | 5 | 65.5% | 5.2% | <0.001 | | Albumin (g/dL) | | | NS | | Hemoglobin (g/L) | | | 0.01 | | Hematocrit (%) | | | 0.01 | | BUN (mg/dL) | | | <0.001 | | Creatinine (mg/dL) | | | <0.001 | | eGFR (mL/min) | | | <0.001 | | Calcium (mg/dL) | | | NS | | Phosphate (mg/dL) | | | NS | | Intact-PTH (pg/mL) | | | <0.001 | | P-cresyl sulfate (mg/L) | | | <0.001 |
|
|
